CAIX Regulates Invadopodia Formation through Both a pH-Dependent Mechanism and Interplay with Actin Regulatory Proteins
<p>CAIX is present in active invadopodia and colocalizes with invadopodial marker cortactin. (<b>A</b>) Immunofluorescent analysis of hypoxia pre-incubated HT1080 cells shows colocalization of CAIX (green) and cortactin (red) in the perinuclear area, marked by a white ellipse, within only 5 h after cells seeding onto a collagen layer. (<b>B</b>) CAIX also colocalizes with F-actin (red) in protruding invadopodium as documented by z-stack analysis of cells cultured for 24 h on collagen. (<b>C</b>) C33 cells transfected with CAIX-GFP protein were cultured on the Matrigel layer containing DQ-BSA as a marker of proteolytic activity (red). Panel (<b>D</b>) shows the intensity profile of CAIX and DQ-BSA signals along the green line denoted in (<b>C</b>). Overlapping peaks of green CAIX signal with red peaks indicating spots with proteolytic degradation of the matrix. (<b>E</b>) After osmotic lysis of HT1080 cells cultured on gelatin for 48 h in hypoxia the invadopodia entrapped within a gelatin layer were visualized by immunofluorescence (CAIX – green, cortactin - red). The right panels show xz-sections of invadopodia, indicated by white arrows, across the matrix depth. (<b>F</b>) Representative Western blot analysis of cell body fraction and isolated invadopodia of HT1080 cells confirms the presence of CAIX in the invadopodial fraction, together with the active form of PKA which phosphorylates CAIX.</p> "> Figure 2
<p>CAIX colocalizes with bicarbonate transporter NBCe1 in HT1080 cells seeded on collagen. After 5h of invadopodia assembly in 2% hypoxia, the samples were stained for NBCe1 and cortactin (<b>A</b>) and NBCe1 together with CAIX (<b>B</b>). Nuclear DAPI staining is blue. Confocal microscopy analysis revealed the occurrence of bicarbonate transporters within invading cells and their colocalization with CAIX and the invadopodial marker cortactin. The coincident distribution of both mentioned protein pairs was observed in the close proximity to the nucleus.</p> "> Figure 3
<p>CAIX expression promotes invadopodia formation and increases the efficiency of extracellular matrix digestion. (<b>A</b>) Representative Western blot proving a high efficiency of transient CA9 silencing in hypoxia-cultured HT1080 cancer cells. (<b>B</b>) Hypoxic CA9-attenuated (siCA9) and control CAIX expressing (siCTRL) HT1080 cells were grown for 5 h on FITC-collagen which allowed us to define the plane of the substrate. Samples were fixed and fluorescently stained for cortactin (N = 23 cells, in two independent experiments). CAIX expressing cells (siCTRL) show a higher number of cortactin-containing invadopodia characterized by stronger fluorescent intensity in comparison to CA9-suppressed cells (siCA9). These results indicate a stimulating role of CAIX in the cortactin accumulation during the invadopodia precursor assembly. (<b>C</b>) Analysis of the overall area covered by cortactin-containing invadopodia in individual cells. The graph shows mean ± stdev of cortactin-stained area fractions, calculated as a percentage of the total cell area. Cell areas were determined according to corresponding transmitted light (DIC) images. The area covered by cortactin-stained invadopodial plaques was significantly reduced in CA9-silenced cells (<span class="html-italic">t</span>-test, * <span class="html-italic">p</span> ≤ 0.05). (D-I) Hypoxic HeLa cells were seeded on the Matrigel layer mixed with DQ-BSA providing a red signal after active invadopodia-mediated focalized digestion of ECM. (<b>D</b>) Representative images of control (siCTRL) and CA9-attenuated cells (siCA9) taken with (upper row) and without transmitted light (bottom row) indicating impaired Matrigel cleavage by CA9-suppressed cells. Right-hand panel shows zoomed-in area of ECM digestion in a control cell. A green line indicates the position of z-section across the matrix depth displayed below. (<b>E</b>) Histogram of numbers of matrix degradation spots sorted by the intensity of DQ-BSA signal, reflecting efficiency of invadopodial proteolytic activity, in CAIX expressing and CA9 silenced cells (<span class="html-italic">N</span> = 21 for each sample in two independent experiments). (<b>F</b>) Graph shows the total level of positive fluorescent signal originating from digested matrix for all 21 CAIX expressing and CA9-depleted cells. Data were processed separately for each plane, from the substrate plane (0) to planes located deeper inside the Matrigel (1 to 4). The signal evaluation includes the overall area of digestion as well as the intensity of digested spots. (<b>G</b>) 3D model of digested matrix signal (DQ-BSA) created for representative images of CAIX expressing (upper panel) and CA9-attenuated cells (lower). The modeling was done in 3D Viewer plugin in ImageJ from substacks of ECM planes, where digestion takes place. Cell outlines were drawn according to corresponding DIC images of cells. (<b>H</b>) Total level of digested matrix signal summed up for all planes for all processed cells confirming a higher efficiency of Matrigel digestion of CAIX positive cells. (I) Histogram of numbers of matrix digestion spots sorted by the intensity of DQ-BSA signal comparing cells (<span class="html-italic">N</span> = 21) treated with HSFA, which inhibits catalytic activity of CAIX, and cells with fully active CAIX (DMSO, <span class="html-italic">N</span> = 21).</p> "> Figure 4
<p>CA9 silencing affects the protein level of invadopodia-associated molecules and influences cancer cell invasion (<b>A</b>) Representative Western blot analysis of hypoxia pre-incubated HT1080 and HeLa cells transiently silenced by siCA9. Cells were seeded on gelatin and cultured in 2% hypoxia for further 24 h. CA9 silencing led to reduced protein levels of Arp2 and a phosphorylated form of cortactin in both cell lines. Total level of cortactin remained unchanged. In HT1080, CA9 downregulation also resulted in a decreased level of integrin beta3. This type of integrin was not detected in HeLa. Arp2 and integrin beta3 are involved in invadopodia formation; phosphorylation of Y421 at cortactin is essential for maturation of invadopodia precursors. (<b>B</b>) Invasion ability of hypoxia pre-incubated HT1080 cells expressing CAIX and with CA9 silenced was assessed using real-time measurement by xCELLigence device. Cells were seeded in a collagen-coated Boyden chamber, under HGF treatment, and stimulated into invasion toward a chemoattractant in the lower chamber. CAIX expressing cells invade faster than their counterparts without CAIX as shown by higher cell index values, which reflect the number of cells that penetrated through a collagen layer. The graph shows time dependence of the cell index expressed as mean±stdev of quadruplicates. The experiment was repeated three times.</p> "> Figure 5
<p>The effect of CAIX on invasion of hypoxic tumor cells in the quail chorioallantoic membrane (CAM) model. Hypoxia pre-incubated TE-1 cells (48 h, 1% O<sub>2</sub>) were grafted onto the day 7 quail embryo and cultivated <span class="html-italic">ex ovo</span> for 3 days. Hematoxylin and Eosin staining, and imunohistochemical staining of CAIX. (<b>A</b>) Hypoxic tumor cells (outlined by dashed line) invaded into CAM and formed metastatic foci (marked by asterisks) in the mesoderm (M) which are positive for CAIX staining. Left image: hematoxylin and eosin staining, right image: immunostaining of CAIX. Tumor cells adhering on the ectoderm layer of CAM are indicated by arrows. (<b>B</b>) Immunostaining of CAIX of control, untreated cells invading into the mesoderm (M). Left image: clusters of migrating cells display CAIX localization at the invasive front (denoted by asterisks). Right image: distribution of CAIX into invadopodium penetrating the ectoderm layer. (<b>C</b>) Effect of anti-CAIX antibodies on invasion ability of TE-1 cells. Hypoxia pre-incubated TE-1 cells were treated by anti-CAIX antibodies before the seeding on CAM. Ab10 antibody targeting the carbonic anhydrase domain completely inhibited the metastatic properties of cancer cells. Anti-PG antibody (M75) strongly suppressed the invasive capability of TE1 cells. Scale bars 50 µm. Ectoderm layer of CAM (ET), mesoderm (M). (<b>D</b>) The effect of CAIX targeting antibodies on hypoxic tumor cell invasion into CAM. The invasion process was divided into five stages. Increasing numbers denote gradually advancing invasion. The stages 1 to 5 are defined as follows: (1) no cells invading into CAM; (2) only a few invading cells which penetrate the ectoderm layer; (3) cells started invading the mesoderm; small clusters are being formed; (4) cells invaded into the mesoderm, metastatic foci had already been formed, (5) considerable metastasis throughout the whole CAM structure. Five CAMs with grafted cells were assessed for each sample during two independent experiments. The values in the table give the portions (in %) of all evaluated CAMs (from both experiments) allocated to separate stages.</p> "> Figure 6
<p>Treatment with CAIX-targeting antibodies prevents extensive lung metastasis formation during <span class="html-italic">in vivo</span> colonization assay. (<b>A</b>) Representative ex vivo images of fluorescent lung metastases of control mice (top panel), of mice treated with Ab10 antibody against the catalytic domain of CAIX and mice treated with M75 antibody against CAIX proteoglycan domain. Ex vivo imaging was performed 12 days after inoculation of RFP-labeled HT1080 cells using IVIS Caliper. Different stages of lung infiltration by HT1080-RFP cells correspond to the intensity and extent of the fluorescent signal. Scale of fluorescence intensity is shown on the right side of the picture with yellow color representing the strongest emission. (<b>B</b>) Box plot graph shows signal distribution of all analyzed lungs based on total radiant efficiency values. Higher total radiant efficiency values mean higher number of fluorescence emitting cells metastasizing into lungs. The lines denote median values. Control mice show a trend toward a higher lung signal than antibody-treated mice. These results indicate that cells expressing fully active CAIX protein with no domain blockage are more likely to succeed in extravasation and metastasis initiation than their counterparts treated with antibodies against CAIX.</p> "> Figure 7
<p>Hypothetical model depicting the consequences of downregulation of CAIX expression (denoted by blue circles) on mechanisms that modulate processes required for the invadopodia development. Acidic extracellular pH is indispensable for invadopodia formation, proteolytic cleavage of extracellular matrix and cancer cell invasion. Enzymatic activity of CAIX regulated by protein kinase A (PKA) generates acidic pHe nanodomains promoting the activity of MMPs. The functional cooperation between CAIX and bicarbonate transporters (NBCe1) in invadopodia locally increases pHi and releases pH-dependent cortactin-cofilin binding to promote actin-free barbed end formation. When CAIX is depleted, extracellular pH increases, intracellular pH becomes less alkaline, phosphorylation of Y421-cortactin is reduced, and Arp2 expression is lowered. These CAIX-related changes attenuate invadopodia formation and actin polymerization. Altogether, CAIX-mediated pH regulation as well as CAIX expression enhances proteolytic activity in invadopodia and affects actin-regulating proteins essential for invadopodia elongation.</p> ">
Abstract
:1. Introduction
2. Results
2.1. The CAIX Protein Distributes to Proteolytically Active Invadopodia
2.2. Bicarbonate Transporter NBCe1 Colocalizes with Cortactin and CAIX in Invadopodia
2.3. Suppression of CAIX Reduces Invadopodia Formation
2.4. Loss of CAIX Decreases Levels of Invadopodia Components and Signaling
2.5. Treatment of Tumor Cells with CAIX Targeting Antibodies Suppresses Their Metastatic Properties
2.6. Effect of anti-CAIX Antibody Treatment on Experimental Lung Metastasis of HT1080 Cells
3. Discussion
4. Materials and Methods
4.1. Cell Culture
4.2. Transient Silencing
4.3. Immunoblotting
4.4. Stable Transfection
4.5. Immunofluorescence
4.6. Cell Fractioning
4.7. Quantification of Invadopodia Formation via Cortactin Staining
4.8. Cell Invasion Assay
4.9. Matrigel Degradation Assay
4.10. Quail Chorioallantoic Membrane (CAM) Model
4.11. Tumor Cells Implantation
4.12. Immunohistochemistry
4.13. In Vivo Model of Experimental Metastasis
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Paz, H.; Pathak, N.; Yang, J. Invading one step at a time: The role of invadopodia in tumor metastasis. Oncogene 2014, 33, 4193–4202. [Google Scholar] [CrossRef] [PubMed]
- Buccione, R.; Caldieri, G.; Ayala, I. Invadopodia: Specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev. 2009, 28, 137–149. [Google Scholar] [CrossRef] [PubMed]
- Busco, G.; Cardone, R.A.; Greco, M.R.; Bellizzi, A.; Colella, M.; Antelmi, E.; Mancini, M.T.; Dell’Aquila, M.E.; Casavola, V.; Paradiso, A.; et al. NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space. Faseb J. 2010, 24, 3903–3915. [Google Scholar] [CrossRef] [PubMed]
- Magalhaes, M.A.O.; Larson, D.R.; Mader, C.C.; Bravo-Cordero, J.J.; Gil-Henn, H.; Oser, M.; Chen, X.; Koleske, A.J.; Condeelis, J. Cortactin phosphorylation regulates cell invasion through a pH-dependent pathway. J. Cell Biol. 2011, 195, 903–920. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gould, C.M.; Courtneidge, S.A. Regulation of invadopodia by the tumor microenvironment. Cell Adh. Migr. 2014, 8, 226–235. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hanna, S.C.; Krishnan, B.; Bailey, S.T.; Moschos, S.J.; Kuan, P.-F.; Shimamura, T.; Osborne, L.D.; Siegel, M.B.; Duncan, L.M.; O’Brien, E.T.; et al. HIF1α and HIF2α independently activate SRC to promote melanoma metastases. J. Clin. Invest. 2013, 123, 2078–2093. [Google Scholar] [CrossRef] [PubMed]
- Lucien, F.; Brochu-Gaudreau, K.; Arsenault, D.; Harper, K.; Dubois, C.M. Hypoxia-Induced Invadopodia Formation Involves Activation of NHE-1 by the p90 Ribosomal S6 Kinase (p90RSK). PLoS ONE 2011, 6, e28851. [Google Scholar] [CrossRef] [PubMed]
- Brisson, L.; Driffort, V.; Benoist, L.; Poet, M.; Counillon, L.; Antelmi, E.; Rubino, R.; Besson, P.; Labbal, F.; Chevalier, S.; et al. NaV1.5 Na+ channels allosterically regulate the NHE-1 exchanger and promote the activity of breast cancer cell invadopodia. J. Cell Sci. 2013, 126, 4835–4842. [Google Scholar] [CrossRef] [PubMed]
- Pastorekova, S.; Zavadova, Z.; Kostal, M.; Babusikova, O.; Zavada, J. A novel quasi-viral agent, MaTu, is a two-component system. Virology 1992, 187, 620–626. [Google Scholar] [CrossRef]
- Wykoff, C.C.; Beasley, N.J.; Watson, P.H.; Turner, K.J.; Pastorek, J.; Sibtain, A.; Wilson, G.D.; Turley, H.; Talks, K.L.; Maxwell, P.H.; et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000, 60, 7075–7083. [Google Scholar] [PubMed]
- Pastorek, J.; Pastorekova, S. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use. Semin. Cancer Biol. 2015, 31, 52–64. [Google Scholar] [CrossRef] [PubMed]
- Svastova, E.; Hulikova, A.; Rafajova, M.; Zatovicova, M.; Gibadulinova, A.; Casini, A.; Cecchi, A.; Scozzafava, A.; Supuran, C.T.; Pastorek, J.; et al. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 2004, 577, 439–445. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Swietach, P.; Patiar, S.; Supuran, C.T.; Harris, A.L.; Vaughan-Jones, R.D. The role of carbonic anhydrase 9 in regulating extracellular and intracellular pH in three-dimensional tumor cell growths. J. Biol. Chem. 2009, 284, 20299–20310. [Google Scholar] [CrossRef]
- Svastova, E.; Witarski, W.; Csaderova, L.; Kosik, I.; Skvarkova, L.; Hulikova, A.; Zatovicova, M.; Barathova, M.; Kopacek, J.; Pastorek, J.; et al. Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain. J. Biol. Chem. 2012, 287, 3392–3402. [Google Scholar] [CrossRef] [PubMed]
- Ditte, P.; Dequiedt, F.; Svastova, E.; Hulikova, A.; Ohradanova-Repic, A.; Zatovicova, M.; Csaderova, L.; Kopacek, J.; Supuran, C.T.; Pastorekova, S.; et al. Phosphorylation of carbonic anhydrase ix controls its ability to mediate extracellular acidification in hypoxic tumors. Cancer Res. 2011, 71, 7558–7567. [Google Scholar] [CrossRef] [PubMed]
- Swayampakula, M.; McDonald, P.C.; Vallejo, M.; Coyaud, E.; Chafe, S.C.; Westerback, A.; Venkateswaran, G.; Shankar, J.; Gao, G.; Laurent, E.M.N.; et al. The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion. Oncogene 2017, 36, 6244–6261. [Google Scholar] [CrossRef] [Green Version]
- Lee, S.-H.; McIntyre, D.; Honess, D.; Hulikova, A.; Pacheco-Torres, J.; Cerdan, S.; Swietach, P.; Harris, A.L.; Griffiths, J.R. Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo. Br. J. Cancer 2018, 119, 622–630. [Google Scholar] [CrossRef]
- Cardone, R.A.; Bellizzi, A.; Busco, G.; Weinman, E.J.; Dell’Aquila, M.E.; Casavola, V.; Azzariti, A.; Mangia, A.; Paradiso, A.; Reshkin, S.J. The NHERF1 PDZ2 domain regulates PKA–RhoA–p38-mediated NHE1 activation and invasion in breast tumor cells. Mol. Biol. Cell 2007, 18, 1768–1780. [Google Scholar] [CrossRef]
- Greco, M.R.; Antelmi, E.; Busco, G.; Guerra, L.; Rubino, R.; Casavola, V.; Reshkin, S.J.; Cardone, R.A. Protease activity at invadopodial focal digestive areas is dependent on NHE1-driven acidic pHe. Oncol. Rep. 2014, 31, 940–946. [Google Scholar] [CrossRef]
- Oser, M.; Yamaguchi, H.; Mader, C.C.; Bravo-Cordero, J.J.; Arias, M.; Chen, X.; DesMarais, V.; van Rheenen, J.; Koleske, A.J.; Condeelis, J. Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J. Cell Biol. 2009, 186, 571–587. [Google Scholar] [CrossRef] [Green Version]
- Frantz, C.; Barreiro, G.; Dominguez, L.; Chen, X.; Eddy, R.; Condeelis, J.; Kelly, M.J.S.; Jacobson, M.P.; Barber, D.L. Cofilin is a pH sensor for actin free barbed end formation: Role of phosphoinositide binding. J. Cell Biol. 2008, 183, 865–879. [Google Scholar] [CrossRef] [PubMed]
- Artym, V.V.; Zhang, Y.; Seillier-Moiseiwitsch, F.; Yamada, K.M.; Mueller, S.C. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: Defining the stages of invadopodia formation and function. Cancer Res. 2006, 66, 3034–3043. [Google Scholar] [CrossRef] [PubMed]
- Sibony-Benyamini, H.; Gil-Henn, H. Invadopodia: The leading force. Eur. J. Cell Biol. 2012, 91, 896–901. [Google Scholar] [CrossRef] [PubMed]
- Oser, M.; Mader, C.C.; Gil-Henn, H.; Magalhaes, M.; Bravo-Cordero, J.J.; Koleske, A.J.; Condeelis, J. Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia. J. Cell Sci. 2010, 123, 3662–3673. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yang, M.; Kozminski, D.J.; Wold, L.A.; Modak, R.; Calhoun, J.D.; Isom, L.L.; Brackenbury, W.J. Therapeutic potential for phenytoin: Targeting Nav1.5 sodium channels to reduce migration and invasion in metastatic breast cancer. Breast Cancer Res. Treat. 2012, 134, 603–615. [Google Scholar] [CrossRef] [PubMed]
- Linder, S.; Wiesner, C.; Himmel, M. Degrading devices: Invadosomes in proteolytic cell invasion. Annu. Rev. Cell Dev. Biol. 2011, 27, 185–211. [Google Scholar] [CrossRef] [PubMed]
- Cmoch, A.; Groves, P.; Pikuła, S. Biogenesis of invadopodia and their cellular functions. Postepy Biochem. 2014, 60, 62–68. [Google Scholar] [PubMed]
- Stoletov, K.; Lewis, J.D. Invadopodia: A new therapeutic target to block cancer metastasis. Expert Rev. Anticancer 2015, 15, 733–735. [Google Scholar] [CrossRef] [PubMed]
- Leong, H.S.; Robertson, A.E.; Stoletov, K.; Leith, S.J.; Chin, C.A.; Chien, A.E.; Hague, M.N.; Ablack, A.; Carmine-Simmen, K.; McPherson, V.A.; et al. Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis. Cell Rep. 2014, 8, 1558–1570. [Google Scholar] [CrossRef] [PubMed]
- Radvak, P.; Repic, M.; Svastova, E.; Takacova, M.; Csaderova, L.; Strnad, H.; Pastorek, J.; Pastorekova, S.; Kopacek, J. Suppression of carbonic anhydrase IX leads to aberrant focal adhesion and decreased invasion of tumor cells. Oncol. Rep. 2013, 29, 1147–1153. [Google Scholar] [CrossRef]
- Cardone, R.A.; Casavola, V.; Reshkin, S.J. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat. Rev. Cancer 2005, 5, 786–795. [Google Scholar] [CrossRef] [PubMed]
- Boedtkjer, E.; Bentzon, J.F.; Dam, V.S.; Aalkjaer, C. Na +, HCO 3 − -cotransporter NBCn1 increases pH i gradients, filopodia, and migration of smooth muscle cells and promotes arterial remodelling. Cardiovasc. Res. 2016, 111, 227–239. [Google Scholar] [CrossRef] [PubMed]
- Robey, I.F.; Nesbit, L.A. Investigating mechanisms of alkalinization for reducing primary breast tumor invasion. Biomed Res. Int. 2013, 2013, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Robey, I.F.; Baggett, B.K.; Kirkpatrick, N.D.; Roe, D.J.; Dosescu, J.; Sloane, B.F.; Hashim, A.I.; Morse, D.L.; Raghunand, N.; Gatenby, R.A.; et al. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res. 2009, 69, 2260–2268. [Google Scholar] [CrossRef] [PubMed]
- Perentes, J.Y.; Kirkpatrick, N.D.; Nagano, S.; Smith, E.Y.; Shaver, C.M.; Sgroi, D.; Garkavtsev, I.; Munn, L.L.; Jain, R.K.; Boucher, Y. Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors. Cancer Res. 2011, 71, 4527–4538. [Google Scholar] [CrossRef] [PubMed]
- Khmara, I.; Koneracka, M.; Kubovcikova, M.; Zavisova, V.; Antal, I.; Csach, K.; Kopcansky, P.; Vidlickova, I.; Csaderova, L.; Pastorekova, S.; et al. Preparation of poly-L-lysine functionalized magnetic nanoparticles and their influence on viability of cancer cells. J. Magn. Magn. Mater. 2017, 427, 114–121. [Google Scholar] [CrossRef]
- Svastova, E.; Zilka, N.; Zatovicova, M.; Gibadulinova, A.; Ciampor, F.; Pastorek, J.; Pastorekova, S. Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin. Exp. Cell Res. 2003, 290, 332–345. [Google Scholar] [CrossRef]
- Parsons-Wingerter, P.; Elliott, K.E.; Farr, A.G.; Radhakrishnan, K.; Clark, J.I.; Sage, E.H. Generational analysis reveals that TGF-β1 inhibits the rate of angiogenesis in vivo by selective decrease in the number of new vessels. Microvasc. Res. 2000, 59, 221–232. [Google Scholar] [CrossRef] [PubMed]
- Zatovicova, M.; Tarabkova, K.; Svastova, E.; Gibadulinova, A.; Mucha, V.; Jakubickova, L.; Biesova, Z.; Rafajová, M.; Ortova Gut, M.; Parkkila, S.; et al. Monoclonal antibodies generated in carbonic anhydrase IX-deficient mice recognize different domains of tumour-associated hypoxia-induced carbonic anhydrase IX. J. Immunol. Methods 2003, 282, 117–134. [Google Scholar] [CrossRef]
- Takacova, M.; Bartosova, M.; Skvarkova, L.; Zatovicova, M.; Vidlickova, I.; Csaderova, L.; Barathova, M.; Breza, J.; Bujdak, P.; Pastorek, J.; et al. Carbonic anhydrase IX is a clinically significant tissue and serum biomarker associated with renal cell carcinoma. Oncol. Lett. 2013, 5, 191–197. [Google Scholar] [CrossRef]
Antigen | Host | Methodology–Dilution | Company |
---|---|---|---|
actin | g | WB - 1:1000 | Santa Cruz |
anion exchanger 2 (AE2) | r | IF - 1:500 | GeneScript–on request [14] |
Arp2 | r | WB - 1:1000 | Santa Cruz (sc-15389) |
carbonic anhydrase IX (CAIX) | m | WB - 1:3 (hybridoma medium) IF - 1:250 (M75-AlexaFluor 488 conjugate) IHC - 1:100 | in house, M75 antibody [9] |
cortactin | m | WB - 1:1000 IF - 1:100 | Millipore (05-180) |
F-actin (phalloidin AF-555) | - | IF - 1:40 | Invitrogen (A34055) |
integrin beta 3 | r | WB - 1:1000 | Abcam (ab75872) |
Ki-67 | m | IHC - 1:100 | DAKO (M7240) |
matrix metalloproteinase 14 (MMP14) | r | WB - 1:1000 | Millipore (AB6004) |
electrogenic sodium bicarbonate cotransporter 1 (NBCe1) | r | IF - 1:100 | Millipore (AB3212) |
paxillin | r | IF - 1:250 | Santa Cruz (sc-5574) |
phospho-cortactin | r | WB - 1:1000 | Cell Signaling (4569) |
phospho- protein-kinase A (p-PKA) | r | WB - 1:1000 | Cell Signaling (5661S) |
protein-kinase A (PKA) | r | WB - 1:1000 | Cell Signaling (4782S) |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Debreova, M.; Csaderova, L.; Burikova, M.; Lukacikova, L.; Kajanova, I.; Sedlakova, O.; Kery, M.; Kopacek, J.; Zatovicova, M.; Bizik, J.; et al. CAIX Regulates Invadopodia Formation through Both a pH-Dependent Mechanism and Interplay with Actin Regulatory Proteins. Int. J. Mol. Sci. 2019, 20, 2745. https://doi.org/10.3390/ijms20112745
Debreova M, Csaderova L, Burikova M, Lukacikova L, Kajanova I, Sedlakova O, Kery M, Kopacek J, Zatovicova M, Bizik J, et al. CAIX Regulates Invadopodia Formation through Both a pH-Dependent Mechanism and Interplay with Actin Regulatory Proteins. International Journal of Molecular Sciences. 2019; 20(11):2745. https://doi.org/10.3390/ijms20112745
Chicago/Turabian StyleDebreova, Michaela, Lucia Csaderova, Monika Burikova, Lubomira Lukacikova, Ivana Kajanova, Olga Sedlakova, Martin Kery, Juraj Kopacek, Miriam Zatovicova, Jozef Bizik, and et al. 2019. "CAIX Regulates Invadopodia Formation through Both a pH-Dependent Mechanism and Interplay with Actin Regulatory Proteins" International Journal of Molecular Sciences 20, no. 11: 2745. https://doi.org/10.3390/ijms20112745
APA StyleDebreova, M., Csaderova, L., Burikova, M., Lukacikova, L., Kajanova, I., Sedlakova, O., Kery, M., Kopacek, J., Zatovicova, M., Bizik, J., Pastorekova, S., & Svastova, E. (2019). CAIX Regulates Invadopodia Formation through Both a pH-Dependent Mechanism and Interplay with Actin Regulatory Proteins. International Journal of Molecular Sciences, 20(11), 2745. https://doi.org/10.3390/ijms20112745